Tybourne Capital Management 13F holdings, Q3 2022
Holdings as of September 30, 2022 · filings on SEC EDGAR · latest filing →
Tybourne Capital Management disclosed 26 US equity positions worth $1.0bn in its Q3 2022 13F filing. The largest position was AMZN at 8.3% of the reported book, followed by CANADIAN PACIFIC RAILWAY LTD (CP US) and MSFT. Against the Q2 2022 filing, it opened 1 new position, added to 2 and reduced 21 among the top 26 holdings.
What did Tybourne Capital Management own in Q3 2022? Top 26 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2022 |
|---|---|---|---|---|---|---|---|
| 1 | AMZN AMAZON.COM INC (AMZN US) | Consumer Cyclical | 8.3% | $85.9m | 760,400 | -25% | reduced |
| 2 | CANADIAN PACIFIC RAILWAY LTD (CP US) | 7.8% | $81.3m | 1,219,135 | -23% | reduced | |
| 3 | MSFT MICROSOFT CORP (MSFT US) | Technology | 7.5% | $78.1m | 335,300 | -23% | reduced |
| 4 | V VISA INC-CLASS A SHARES (V US) | Financial Services | 7.1% | $73.9m | 416,051 | -19% | reduced |
| 5 | MELI MERCADOLIBRE INC (MELI US) | Consumer Cyclical | 6.3% | $65.7m | 79,331 | -25% | reduced |
| 6 | SPGI S&P GLOBAL INC (SPGI US) | Financial Services | 6.1% | $63.2m | 206,917 | -23% | reduced |
| 7 | BEKE KE HOLDINGS INC-ADR (BEKE US) | Real Estate | 5.9% | $61.8m | 3,529,967 | -20% | reduced |
| 8 | LIN LINDE PLC (LIN US) | Basic Materials | 5.0% | $52.0m | 192,947 | -10% | reduced |
| 9 | ZNTL ZENTALIS PHARMACEUTICALS INC (ZNTL US) | Healthcare | 4.8% | $49.9m | 2,301,771 | -5% | reduced |
| 10 | HTHT H WORLD GROUP LTD (HTHT US) | Consumer Cyclical | 4.7% | $48.8m | 1,454,769 | -18% | reduced |
| 11 | LRCX LAM RESEARCH CORP (LRCX US) | Technology | 4.4% | $45.6m | 124,600 | 23% | added |
| 12 | NVDA NVIDIA CORP (NVDA US) | Technology | 4.2% | $43.9m | 361,514 | 124% | added |
| 13 | SE SEA LTD-ADR (SE US) | Consumer Cyclical | 3.5% | $36.8m | 655,726 | -24% | reduced |
| 14 | QCOM QUALCOMM INC (QCOM US) | Technology | 2.9% | $30.5m | 270,136 | -22% | reduced |
| 15 | SHOP SHOPIFY INC - CLASS A (SHOP US) | Technology | 2.9% | $30.3m | 1,126,410 | -23% | reduced |
| 16 | STNE STONECO LTD-A (STNE US) | Technology | 2.7% | $28.3m | 2,973,363 | -23% | reduced |
| 17 | TWLO TWILIO INC - A (TWLO US) | Technology | 2.7% | $27.7m | 400,210 | -21% | reduced |
| 18 | XYZ BLOCK INC (SQ US) | Technology | 2.5% | $26.0m | 473,700 | -24% | reduced |
| 19 | BCYC BICYCLE THERAPEUTICS LTD-ADR (BCYC US) | Healthcare | 2.3% | $24.2m | 1,041,331 | -10% | reduced |
| 20 | SNOW SNOWFLAKE INC-CLASS A (SNOW US) | Technology | 1.9% | $19.5m | 114,500 | -38% | reduced |
| 21 | TXN TEXAS INSTRUMENTS INC (TXN US) | Technology | 1.7% | $17.5m | 112,833 | -61% | reduced |
| 22 | MDB MONGODB INC (MDB US) | Technology | 1.5% | $15.2m | 76,298 | -42% | reduced |
| 23 | TEAM ATLASSIAN CORP -CLASS A (TEAM US) | Technology | 1.4% | $15.0m | 71,200 | – | new |
| 24 | INHIBRX INC (INBX US) | 1.1% | $11.6m | 645,815 | -19% | reduced | |
| 25 | LIANY LIANBIO-ADR (LIAN US) | 0.6% | $6.6m | 3,303,573 | -0% | held | |
| 26 | TSHA TAYSHA GENE THERAPIES INC (TSHA US) | Healthcare | 0.1% | $965.0k | 500,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.